K252711 is an FDA 510(k) clearance for the Advantage-C™ Ti3D Cervical Interbody Fusion Device. This device is classified as a Intervertebral Fusion Device With Bone Graft, Cervical (Class II - Special Controls, product code ODP).
Submitted by Intelivation Technologies (Plymouth Meeting, US). The FDA issued a Cleared decision on January 8, 2026, 134 days after receiving the submission on August 27, 2025.
This device falls under the Orthopedic FDA review panel. Regulated under 21 CFR 888.3080. Intended To Stabilize Cervical Spinal Segment To Promote Fusion In Order To Restrict Motion And Decrease Pain Using Bone Graft..